Loading news...
Insightful Analysis of Lee Ainslie (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Lee Ainslie (Trades, Portfolio) recently submitted the 13F filing for t
Kenvue investors approve its sale to Kimberly-Clark. Stock nears 52-week lows ahead of February earnings, with mixed technical signals and cautious analyst ratings.
Eubel Brady and Suttman Asset Management Inc. boosted its stake in Kenvue Inc. (NYSE: KVUE) by 39.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,371,886 shares of the company's stock after purchasing an additional 389,704 shares during the period. Kenvue
Dividend Kings remain broadly overvalued, with only a handful approaching fair price despite elevated yields. Three Dividend Kings—Canadian Utilities, Fortis, and Hormel—currently meet the dogcatcher 'ideal' but face dividend safety concerns due to negative free cash flow margins. Analyst projections estimate 14.16% to 27.77% net gains for top-yielding Dividend Kings by February 2027, with ABBV and NWN ranking in the top 20 across yield, target, and returns.
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on mor.
Pre-Market Stock Futures: Futures are trading lower as we prepare to close out the trading week. What a difference a day can make. After a blockbuster rally on Wednesday, the stock market reversed course and sold off on Thursday, and that could carry over into today. While the major indices ended off their midday lows,... Here Are Friday's Top Wall Street Analyst Research Calls: Broadcom, Circle Internet, Kenvue, Medtronic, Sandisk, Southwest Airlines, Spotify, and More.
Key Milestone in Creating a Global Health and Wellness Leader Transaction Expected to Close in the Second Half of 2026 DALLAS and SUMMIT, N.J., Jan. 29, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) today announced that Kimberly-Clark and Kenvue shareholders voted overwhelmingly to approve all of the proposals necessary for Kimberly-Clark to complete its acquisition of Kenvue at their respective Special Meetings of Stockholders held today.
Shares of Kenvue Inc. (NYSE: KVUE - Get Free Report) have received a consensus recommendation of "Hold" from the eighteen brokerages that are currently covering the firm, Marketbeat reports. Twelve research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders of record as of the close of business on February 11, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, John.
Kimberly-Clark reported a higher profit in its latest quarter just days before shareholders vote on its plan to buy Kenvue, a deal designed to create a global health-and-wellness giant.
Investment House LLC decreased its holdings in Kenvue Inc. (NYSE: KVUE) by 75.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,084 shares of the company's stock after selling 93,597 shares during the quarter. Investment House LLC's holdings in Kenvue were
Callahan Advisors LLC purchased a new position in shares of Kenvue Inc. (NYSE: KVUE) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 80,523 shares of the company's stock, valued at approximately $1,307,000. Several other hedge funds also recently added to or reduced
Taking paracetamol, known as Tylenol in the U.S., during pregnancy is safe, a group of European researchers have said, after compiling data in response to U.S. President Donald Trump's claims of a link to autism last year.
Institutional Shareholder Services on Friday recommended that shareholders approve plans by Kleenex maker Kimberly-Clark to buy Tylenol maker Kenvue, saying a tie-up could improve financial metrics.
Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Kenvue Inc. (NYSE: KVUE) by 27.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 310,686 shares of the company's stock after purchasing an additional 66,192 shares during
Oregon Public Employees Retirement Fund increased its position in Kenvue Inc. (NYSE: KVUE) by 32.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 219,333 shares of the company's stock after acquiring an additional 53,387 shares during the period. Oregon
Birch Hill Investment Advisors LLC decreased its position in Kenvue Inc. (NYSE: KVUE) by 57.2% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,488 shares of the company's stock after selling 83,483 shares during the quarter. Birch Hill Investment Advisors
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Davis Capital Management purchased a new position in shares of Kenvue Inc. (NYSE: KVUE) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,872 shares of the company's stock, valued at approximately $647,000. A number of other large investors also recently
Insider buying can be one of the cleanest “follow-the-money” signals in the market. Over the past month or so, three names have stood out for $100 million-plus buying tied to prominent funds and well-known professional investors.